Opiate abuse, innate immunity, and bacterial infectious diseases

Archivum Immunologiae et Therapiae Experimentalis

Volumn 56, Issue 5, 2008, Pages 299-309

  Wang, Jinghua ^a   Barke, Roderick A ^b   Ma, Jing ^a,c   Charboneau, Richard ^b   Roy, Sabita ^a,b,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Basic Medical College   (China)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

T lymphocytes; Bacterial infection; Cytokines; Dentritic cells; Innate immunity; Macrophages; Morphine; Neutrophils; NK cells; Opiate

Indexed keywords

BETA FUNALTREXAMINE; CHEMOKINE; CYTOKINE; MORPHINE; NALOXONE; OPIATE DERIVATIVE; TOLL LIKE RECEPTOR;

ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG ABUSE; DRUG INHIBITION; EPITHELIUM; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTE; REVIEW;

ANIMALS; BACTERIAL INFECTIONS; CYTOKINES; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, INNATE; OPIOID-RELATED DISORDERS;

EID: 53849089552     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-008-0035-0     Document Type: Review

References (93)

1. Albiger B., Dahlberg S., Henriques-Normark B. and Normark S. (2007): Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. J. Intern. Med., 261, 511-528.
2. Asakura H., Kawamoto K., Igimi S., Yamamoto S. and Makino S. (2006): Enhancement of mice susceptibility to infection with Listeria monocytogenes by the treatment of morphine. Microbiol. Immunol., 50, 543-547.
3. Belzunegui J., Rodríguez-Arrondo F., González C., Queiro R., Martínez de Bujo M., Intxausti J. J., De Dios J. R. and Figueroa M. (2000): Musculoskeletal infections in intravenous drug addicts: report of 34 cases with analysis of microbiological aspects and pathogenic mechanisms. Clin. Exp. Rheumatol., 18, 383-386.
4. Bhat R. S., Bhaskaran M., Mongia A., Hitosugi N. and Singhal P. C. (2004): Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J. Leukoc. Biol., 75, 1131-1138.
5. Bonnet M. P., Beloeil H., Benhamou D., Mazoit J. X. and Asehnoune K. (2008): The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in Toll-like receptor 2-stimulated monocytes. Anesth. Analg., 106, 1142-1149.
6. Borish L., Rosenbaum R., Albury L. and Clark S. (1989): Activation of neutrophils by recombinant interleukin 6. Cell. Immunol., 121, 280-289.
7. Born W. K., Reardon C. L. and O'Brien R. L. (2006): The function of gammadelta T cells in innate immunity. Curr. Opin. Immunol., 18, 31-38.
8. Boschini A., Smacchia C., Di Fine M., Schiesari A., Ballarini P., Arlotti M., Gabrielli C., Castellani G., Genova M., Pantani P., Lepri A. C. and Rezza G. (1996): Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin. Infect. Dis., 23, 107-113.
9. Carr D. J. and France C. P.(1993): Immune alterations in morphine-treated rhesus monkeys. J. Pharmacol. Exp. Ther., 267, 9-15.
10. Casellas A. M., Guardiola H. and Renaud F. L. (1991): Inhibition by opioids of phagocytosis in peritoneal macrophages. Neuropeptides, 18, 35-40.
11. Chao C. C., Sharp B. M., Pomeroy C., Filice G. A. and Peterson P. K. (1990): Lethality of morphine in mice infected with Toxoplasma gondii. J. Pharmacol. Exp. Ther., 252, 605-609.
12. Chen S. Y., Huo Q. L., Huang J. B., Chen Z. L., Shi X. H. and Liao X. L. (1995): Morphine inhibited respiratory burst of neutrophils and scavenged oxygen free radicals. Zhongguo Yao Li Xue Bao, 16, 445-448.
13. Clark J. D., Shi X., Li X., Qiao Y., Liang D., Angst M. S. and Yeomans D. C. (2007): Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol. Pain, 3, 28.
14. Coban C., Ishii K. J. and Kawai T. (2005): Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med., 201, 19-25.
15. Crozat K. and Beutler B. (2004): TLR7: a new sensor of viral infection. Proc. Natl. Acad. Sci. USA, 101, 6835-6836.
16. Delgado-Vélez M., Lugo-Chinchilla A., Lizardo L., Morales I., Robles Y., Bruno N., Rodríguez J. W., Ríos-Olivares E., Correa M. and Renaud F. L. (2008): Chronic exposure of human macrophages in vitro to morphine and methadone induces a putative tolerant/dependent state. J. Neuroimmunol., 196, 94-100.
17. Durante A. J., Selwyn P. A. and O'Connor P. G. (1998): Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment. Addiction, 93, 1393-1401.
18. Dusi S., Della Bianca V., Donini M., Nadalini K. A. and Rossi F. (1996): Mechanisms of stimulation of the respiratory burst by TNF in nonadherent neutrophils: its independence of lipidic transmembrane signalling and dependence on protein tyrosine phosphorylation and cytoskeleton. J. Immunol., 157, 4615-4623.
19. Eisenstein T. K., Bussiere J. L., Rogers T. J. and Adler M. W. (1993): Immunosuppressive effects of morphine on immune responses in mice. Adv. Exp. Med. Biol., 335, 41-52.
20. El-Sharif A. and Ashour H. M. (2008): Community-acquired Methicillin-resistant S. aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers. Exp. Biol. Med., 233, 874-880.
21. Fecho K. and Lysle D. T. (1999): Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat. Cell. Immunol., 195, 137-146.
22. Fecho K., Maslonek K. A., Dykstra L. A. and Lysle D. T. (1996): Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther., 276, 626-636.
23. Fecho K., Maslonek K. A., Dykstra L. A. and Lysle D. T. (1995): Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced immunomodulation. Adv. Exp. Med. Biol., 373, 149-153.
24. Feng P., Rahim R. T., Cowan A., Liu-Chen L. Y., Peng X., Gaughan J., Meissler J. J. Jr., Adler M. W. and Eisenstein T. K. (2006): Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit. Eur. J. Pharmacol., 534, 250-257.
25. Frenklakh L., Bhat R. S., Bhaskaran M., Sharma S., Sharma M., Dinda A. and Singhal P. C. (2006): Morphine-induced degradation of the host defense barrier role of intestinal mucosal injury. Dig. Dis. Sci., 51, 318-325.
26. Gordon S. B., Irving G. R., Lawson R. A., Lee M. E. and Read R. C. (2000): Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect. Immun., 68, 2286-2293.
27. Grimm M. C., Ben-Baruch A., Taub D. D., Howard O. M., Wang J. M. and Oppenheim J. J. (1998): Opiate inhibition of chemokine-induced chemotaxis. Ann. NY Acad. Sci., 840, 9-20.
28. Guarner J., Bartlett J., Reagan S., Fischer M., Finn S., O'Briain D. S., Black M., Hood J. and Zaki S. R. (2006): Immunohistochemical evidence of Clostridium sp, Staphylococcus aureus, and group A Streptococcus in severe soft tissue infections related to injection drug use. Hum. Pathol., 37, 1482-1488.
29. Guo C. J., Li Y., Tian S., Wang X., Douglas S. D. and Ho W. Z. (2002): Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J. Investig. Med., 50, 435-442.
30. Hayashi F., Smith K. D. and Ozinsky A. (2001): The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature, 410, 1099-1103.
31. Hilburger M. E., Adler M. W., Truant A. L., Meissler J. J. Jr., Satishchandran V., Rogers T. J. and Eisenstein T. K. (1997): Morphine induces sepsis in mice. J. Infect. Dis., 176, 183-188.
32. Hind C. R. (1990): Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications. Thorax, 45, 957-961.
33. Hoshino K., Takeuchi O. and Kawai T. (1999): Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol., 162, 3749-3752.
34. Houghtling R. A., Mellon R. D., Tan R. J. and Bayer B. M. (2000): Acute effects of morphine on blood lymphocyte proliferation and plasma IL-6 levels. Ann. NY Acad. Sci., 917, 771-777.
35. Iuvone T., Capasso A., D'Acquisto F. and Carnuccio R. (1995): Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem. Biophys. Res. Commun., 212, 975-980.
36. Kapasi A. A., Coscia S. A., Pandya M. P. and Singhal P. C. (2004): Morphine modulates HIV-1 gp160-induced murine macrophage and human monocyte apoptosis by disparate ways. J. Neuroimmunol., 148, 86-96.
37. Klebanoff S. J., Vadas M. A., Harlan J. M., Sparks L. H., Gamble J. R., Agosti J. M. and Waltersdorph A. M. (1986): Stimulation of neutrophils by tumour necrosis factor. J. Immunol., 136, 4220-4225.
38. Koyuncuoùlu H., Güngör M., Anù O., Inanǧ D., Anù-Küçüker M., Saùduyu H. and Uysal V. (1988): Aggravation by morphine and D-aspartic acid of pyelonephritis induced by i.v. inoculation of Staphylococcus aureus in rats. Infection, 16, 42-45.
39. Laichalk L. L., Kunkel S. L., Strieter R. M., Danforth J. M., Bailie M. B. and Standiford T. J. (1996): Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun., 64, 5211-5218.
40. Lee H. C., Lee N. Y., Chang C. M., Chou C. Y., Wu Y. H., Wang L. R., Ko N. Y., Liu C. C. and Ko W. C. (2007): Outbreak of Acinetobacter baumannii bacteremia related to contaminated morphine used for patient-controlled analgesia. Infect. Control Hosp. Epidemiol., 28, 1213-1217.
41. Liu Y., Blackbourn D. J., Chuang L. F., Killam K. F. Jr. and Chuang R. Y. (1992): Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis. J. Pharmacol. Exp. Ther., 263, 533-539.
42. Lugo-Chinchilla A. M., Báez D., Vélez M., Ildefonso C. and Renaud F. L. (2006): Altered subcellular signaling in murine peritoneal macrophages upon chronic morphine exposure. J. Neuroimmunol., 176, 86-94.
43. Luza J. (1992): Effect of morphine on phagocytic activity of the polymorphonuclears and monocytes. Acta Univ. Palacki Olomuc Fac. Med., 134, 47-50.
44. Lysle D. T., Hoffman K. E. and Dykstra L. A. (1996): Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J. Pharmacol. Exp. Ther., 277, 1533-1540.
45. MacFarlane A. S., Peng X., Meissler J. J. Jr., Rogers T. J., Geller E. B., Adler M. W. and Eisenstein T. K. (2000): Morphine increases susceptibility to oral Salmonella typhimurium infection. J. Infect. Dis., 181, 1350-1358.
46. Martucci C., Franchi S., Lattuada D., Panerai A. E. and Sacerdote P. 2007): Differential involvement of RelB in morphine-induced modulation of chemotaxis, NO, and cytokine production in murine macrophages and lymphocytes. J. Leukoc. Biol., 81, 344-354.
47. McIlroy M. A., Reddy D., Markowitz N. and Saravolatz L. D. (1989): Infected false aneurysms of the femoral artery in intravenous drug addicts. Rev. Infect. Dis., 11, 578-585.
48. Messmer D., Hatsukari I., Hitosugi N., Schmidt-Wolf I. G. and Singhal P. C. (2006): Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Mol. Med., 12, 284-290.
49. Miyagi T., Chuang L. F., Lam K. M., Kung H., Wang J. M., Osburn B. I. and Chuang R. Y. (2000): Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response. Immunopharmacology, 47, 53-62.
50. Mullen P. G., Windsor A. C., Fowler A. A. and Sugerman H. J. (1995): Tumor necrosis factor α and interleukin-6 selectively regulate neutrophil function in vitro. J. Surg. Res., 58, 124-130.
51. Nath A., Hauser K. F., Wojna V., Booze R. M., Maragos W., Prendergast M., Cass W. and Turchan J. T. (2002): Molecular basis for interactions of HIV and drugs of abuse. J. Acquir. Immune Defic. Syndr., 31 (suppl. 2), S62-69.
52. Nelson S. and Summer W. R. (1998): Innate immunity, cytokines and pulmonary host defense. Infect. Dis. Clin. North Am., 12, 555-567.
53. Neumann B., Machleidt T., Lifka A., Pfeffer K., Vestweber D., Mak T. W., Holzmann B. and Krönke M. (1996): Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol., 156,1587-1593.
54. Nizet V. (2007): Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J. Allergy Clin. Immunol., 120, 13-22.
55. Okusawa S., Gelfand J. A., Ikejima T., Connolly R. J. and Dinarello C. A. (1988): Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest., 81, 1162-1172.
56. Olin M. R., Choi K., Lee J., Peterson P. K. and Molitor T. W. (2007): Morphine modulates gammadelta lymphocytes cytolytic activity following BCG vaccination. Brain Behav. Immun., 21, 195-201.
57. Patel J., Manjappa N., Bhat R., Mehrotra P., Bhaskaran M. and Singhal P. C. ( 2003): Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth. Am. J. Physiol. Renal Physiol., 285, F861-869.
58. Patel K., Bhaskaran M., Dani D., Reddy K. and Singhal P. C. (2003): Role of heme oxygenase-1 in morphine-modulated apoptosis and migration of macrophages. J. Infect. Dis., 187, 47-54.
59. Peng X., Mosser D. M., Adler M. W., Rogers T. J., Meissler J. J. Jr. and Eisenstein T. K. (2000): Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages. J. Leukoc. Biol., 68, 723-728.
60. Perez-Castrillon J.-L., Perez-Arellano J.-L., Garcia-Palomo J.-D., Jimenez-Lopez A. and De Castro S. (1992): Opioids depress in vitro human monocyte chemotaxis. Immunopharmacology, 23, 57-61.
61. Perlman D. C., Salomon N., Perkins M. P., Yancovitz S., Paone D. and Des Jarlais D. C.(1995): Tuberculosis in drug users. Clin. Infect. Dis., 21, 1253-1264.
62. Peterson P. K., Gekker G., Hu S., Sheng W. S., Molitor T. W. and Chao C. C. (1995): Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor. Adv. Neuroimmunol., 5, 299-309.
63. Rogers H. W., Tripp C. S., Schreiber R. D. and Unanue E. R. (1994): Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis. J. Immunol., 153, 2093-2101.
64. Rojavin M., Szabo I., Bussiere J. L., Rogers T. J., Adler M. W. and Eisenstein T. K. (1993): Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci., 53, 997-1006.
65. Roy S., Barke R. A. and Loh H. H. (1998): MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res. Mol. Brain Res., 61, 190-194.
66. Roy S., Cain K. J., Chapin R. B., Charboneau R. G. and Barke R. A. (1998): Morphine modulates NF kappa B activation in macrophages. Biochem. Biophys. Res. Commun., 245, 392-396.
67. Roy S., Charboneau R. G., Barke R. A. and Loh H. H. (2001): Role of mu-opioid receptor in immune function. Adv. Exp. Med. Biol., 493, 117-126.
68. Roy S., Wang J. H., Balasubramanian S., Sumandeep, Charboneau R., Barke R., Loh H. H. (2001): Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice. J. Neuroimmunol., 116, 147-155.
69. Saurer T. B., Carrigan K. A., Ijames S. G. and Lysle D. T. (2004): Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT. J. Neuroimmunol., 148, 54-62.
70. Saurer T. B., Ijames S. G. and Lysle D. T. (2006): Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J. Neuroimmunol., 177, 18-26.
71. Sen G. C. and Sarkar S. N. (2005): Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev., 16, 1-14.
72. Shah N. G., Lathrop S. L., Reichard R. R. and Landen M. G. (2008): Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction, 103, 126-136.
73. Singhal P. C., Bhaskaran M., Patel J., Patel K., Kasinath B. S., Duraisamy S., Franki N., Reddy K. and Kapasi A. A. (2002): Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J. Immunol., 168, 4025-4033.
74. Singhal P. C., Kapasi A. A., Franki N. and Reddy K. (2000): Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta. Immunology, 100, 57-62.
75. Singhal P. C., Pamarthi M., Shah R., Chandra D. and Gibbons N. (1994): Morphine stimulates superoxide formation by glomerular mesangial cells. Inflammation, 18, 293-299.
76. Singh R. P., Jhamb S. S. and Singh P. P. (2008): Effects of morphine during Mycobacterium tuberculosis H37Rv infection in mice. Life Sci., 82, 308-314.
77. Smyth M. J., Cretney E., Kelly J. M., Westwood J. A., Street S. E., Yagita H., Takeda K., van Dommelen S. L., Degli-Esposti M. A. and Hayakawa Y. (2005): Activation of NK cell cytotoxicity.Mol. Immunol., 42, 501-510.
78. Stefano G. B., Cadet P., Fimiani C. and Magazine H. I. (2001): Morphine stimulates iNOS expression via a rebound from inhibition in human macrophages: nitric oxide involvement. Int. J. Immunopathol. Pharmacol., 14, 129-138.
79. Steinman R. M. and Hemmi H. (2006): Dendritic cells: translating innate to adaptive immunity. Curr. Top Microbiol. Immunol., 311, 17-58.
80. Sugawara I., Yamada H., Li C., Mizuno S., Takeuchi O. and Akira S. (2003): Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol. Immunol., 47, 327-336.
81. Szabo I., Rojavin M., Bussiere J. L., Eisenstein T. K., Adler M. W. and Rogers T. J. (1993): Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J. Pharmacol. Exp. Ther., 267, 703-706.
82. Ting A. C. and Cheng S. W. (1997): Femoral pseudoaneurysms in drug addicts. World J. Surg., 21, 783-786.
83. Tomassini N., Renaud F. L., Roy S. and Loh H. H. (2003): Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages. J. Neuroimmunol., 136, 9-16.
84. Triantafilou K., Vakakis E. and Orthopoulos G. (2005): TLR8 and TLR7 are involved in the host's immune response to human parechovirus 1. Eur. J. Immunol., 35, 2416-2423.
85. Trinchieri G. and Sher A. (2007): Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol., 7, 179-190.
86. Tubaro E., Borelli G., Croce C., Cavallo G. and Santiangeli C. (1983): Effect of morphine on resistance to infection. J. Infect. Dis., 148, 656-666.
87. Wang J., Barke R. A., Charboneau R. and Roy S. (2005): Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J. Immunol., 174, 426-434.
88. Wang J., Barke R. A., Charboneau R., Schwendener R. and Roy S. (2008): Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappaB signaling. J Immunol., 180, 3594-3600.
89. Wang J., Charboneau R., Balasubramanian S., Barke R. A., Loh H. H. and Roy S. (2002): The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J. Leukoc. Biol., 71, 782-790.
90. Welters I. D., Menzebach A., Goumon Y., Cadet P., Menges T., Hughes T. K., Hempelmann G. and Stefano G. B. (2000): Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology, 92, 1677-1684.
91. Welters I. D., Menzebach A., Goumon Y., Langefeld T. W., Teschemacher H., Hempelmann G. and Stefano G. B. (2000): Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism. J. Neuroimmunol., 111, 139-145.
92. Yossuck P., Nightengale B. J., Fortney J. E. and Gibson L. F. (2008): Effect of morphine sulfate on neonatal neutrophil chemotaxis. Clin. J. Pain, 24, 76-82.
93. Zhang T., Li Y. and Ho W. Z. (2006): Drug abuse, innate immunity and hepatitis C virus. Rev. Med. Virol., 16, 311-327.